Dublin, Nov. 13, 2020 (GLOBE NEWSWIRE) -- The "Global Aesthetic Filler Market 2019-2028" report has been added to ResearchAndMarkets.com's offering.

According to this research report, the global market for aesthetic filler is expected to surge at a CAGR of 10.35% during the evaluated period of 2019-2028.

The growing demand for aesthetic fillers, a surge in healthcare expenditure, rising acceptance of tissue fillers, and a growing aging population are significant factors that augment the aesthetic filler market's progression worldwide. Additionally, the increasing number of men undergoing cosmetic procedures, along with growing awareness about cosmetic procedures, are creating multiple opportunities for the market's future.

However, the negative effect of unregistered practitioners, paired with the high cost of procedures, are significantly weighing down the aesthetic filler market.

The global aesthetic filler market covers the Asia-Pacific, Europe, North America, Latin America, and the Middle East and Africa regions.

The Asia-Pacific is expected to become the fastest-evolving market for aesthetic filler over the estimated period 2019-2028. In China, the younger population is mainly persuaded by westernized looks, which leads them to undergo cosmetic procedures. Among the various procedures, facelift and eyelid surgery, are the most common cosmetic procedures. Additionally, China has the highest number of cosmetic procedures, with growing male customers. The people between 20 and 40 are undergoing cosmetic surgeries, which is enhancing the demand for facial surgeries. This further augments the aesthetic filler market in China, thereby overall APAC region.

The key enterprises involved in the aesthetic filler market are Galderma Pharma SA, Laboratoires Vivacy SAS, Sculpt Luxury Dermal Fillers Ltd, Zhejiang Jingjia Medical Technology Co Ltd, Suneva Medical Inc, Teoxane, Bioxis Pharmaceuticals, Contura Ltd, Prollenium Medical Technologies, Anika Therapeutics Inc, Bioha Laboratories, Allergan, Merz Pharma, Sinclair Pharma, and Ipsen.

Allergen is a global pharmaceutical company that concentrates on manufacturing, and commercializing branded regenerative medicine, pharmaceutical device, surgical, and biologic products for patients. Its product portfolio comprises products for medical aesthetics and dermatology, women's health, and eye care, among others. The company has its headquarter in Ireland, with its operation across all regions.

Key Topics Covered:

1. Global Aesthetic Filler Market - Summary

2. Industry Outlook2.1. Market Definition2.2. Key Insights2.2.1. Increased Awareness About Anti-Aging Measures2.2.2. Increasing Popularity of Minimally Invasive and Non-Invasive Procedures2.3. Impact of COVID-19 on Aesthetic Filler Market2.4. Porter's Five Forces Analysis2.4.1. Threat of New Entrants2.4.2. Threat of Substitute2.4.3. Bargaining Power of Buyers2.4.4. Bargaining Power of Suppliers2.4.5. Threat of Competitive Rivalry2.5. Market Attractiveness Index2.6. Vendor Scorecard2.7. Market Drivers2.7.1. Growing Demand for Facial Aesthetics2.7.2. Rising Acceptance of Tissue Fillers2.7.3. Increasing Aging Population2.7.4. Increase in Healthcare Spending2.8. Market Restraints2.8.1. Negative Effect of Unregistered Practitioners2.8.2. High Cost of Procedure2.9. Market Opportunities2.9.1. Increasing Number of Men Undergoing Cosmetic Procedures and Awareness About Cosmetic Procedures2.9.2. Increase in Beauty Consciousness and Disposable Income2.9.3. Advancements in Facial Rejuvenation2.10. Market Challenges2.10.1. Challenges Arising from Reimbursement Issues, Social Stigma, and Rapidly Advancing Technologies2.10.2. Side Effects Associated with Dermal Fillers

3. Global Aesthetic Filler Market Outlook - by Product Type3.1. Wrinkle Relaxers3.2. Dermal Fillers3.2.1. Collagen3.2.2. Hyaluronic Acid3.2.3. Fat Injection3.2.4. Polylactic Acid3.2.5. Polymethyl Methacrylate Microspheres (Pmma)3.2.6. Calcium Hydroxylapatite

4. Global Aesthetic Filler Market Outlook - by Application4.1. Facial Line Correction4.2. Lip Treatment4.3. Face Lift4.4. Acne Scar Treatment4.5. Lipoatrophy Treatment4.6. Others

5. Global Aesthetic Filler Market - Regional Outlook5.1. North America5.2. Europe5.3. Asia-Pacific5.4. Latin America5.5. Middle East and Africa

6. Competitive Landscape6.1. Allergan (Acquired by Abbvie)6.2. Galderma Pharma Sa (Acquired by Eqt)6.3. Laboratoires Vivacy Sas6.4. Merz Pharma6.5. Sinclair Pharma6.6. Suneva Medical Inc6.7. Teoxane6.8. Anika Therapeutics Inc6.9. Bioha Laboratories6.10. Bioxis Pharmaceuticals6.11. Contura Ltd6.12. Prollenium Medical Technologies6.13. Zhejiang Jingjia Medical Technology Co Ltd6.14. Sculpt Luxury Dermal Fillers Ltd6.15. Ipsen

7. Methodology & Scope

For more information about this report visit https://www.researchandmarkets.com/r/v0qj9e

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Read more from the original source:
The Worldwide Industry for Aesthetic Fillers is Expected to Grow at a CAGR of 10.35% Between 2019 and 2028 - GlobeNewswire